IGS1 fundamentals
An in-depth look to IGC PHARMA INC operating, investing, and financing activities
IGS1 free cash flow for Q4 23 is -501.39 k EUR. For 2023, IGS1 free cash flow was -4.95 M EUR and operating cash flow was -4.82 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM